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Abstract
Background: A substantial fraction of UK general practitioners’ salaries is now intended to reflect the quality of
care provided. This performance-related pay system has probably improved aspects of primary health care but,
using the observational data available, disentangling the impacts of different types of targets set within this unique
payment system is challenging.
Discussion: Financial incentives undoubtedly influence GPs’ activities, however, those aimed at encouraging GPs’
delivery of health promotion counselling may not always have the effects intended. There is strong, observational
evidence that targets and incentives intended to increase smoking cessation counselling by GPs have merely
increased their propensity to record this activity in patients’ medical records. The limitations of using financial
incentives to stimulate the delivery of counselling in primary care are discussed and a re-appraisal of their use
within UK GPs’ performance-related pay system is argued for.
Summary: The utility of targets employed by the system for UK General Practitioners’ performance related pay
may be inappropriate for encouraging the delivery of health promotion counselling interventions. An evaluation of
these targets is essential before they are further developed or added to.
Background
Since 2004, UK general practitioners’ (GPs’) remunera-
tion has been partially performance-related, governed by
the Quality and Outcomes Framework (QOF) [1,2].
Through the QOF, GPs receive payments, representing
up to 20% of their income [3], for compliance with tar-
gets (called ‘indicators’) set across the whole spectrum
of clinical activity. General practices decide how pay-
ments are used and there is no requirement for these to
be shared amongst the primary health care team; any
diffusion of incentive payments to non-GP staff is con-
trolled by those who run practices (usually GPs). Obser-
vational studies investigating this vast health system
experiment show that the QOF has improved asthma
and diabetes care [4,5]. Recorded care of cardiovascular
disease is also better than before 2004 [4], but since the
QOF there has been no acceleration in the rate of
improvement [4,5]. Targets set in any incentives-based
quality management system are of crucial importance
and QOF indicators need to be regularly revised to
ensure that they continue to stimulate further improve-
ments in health care [6]. However, the validity of some
QOF indicators for producing their intended effects is
questionable. For example, GPs can comply with QOF
targets for advising patients against smoking without
actually delivering any useful or effective counselling.
W h i l s tt h eQ O Fs e e m st oh a v ee n c o u r a g e dt h eu s eo f
effective diagnostic and drug interventions, it may not
be an appropriate mechanism for promoting delivery of
health promotion counseling and QOF indicators which
rely on clinicians’ records of having counseled or
advised patients may be particularly prone to unin-
tended consequences.
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QOF clinical indicators: validity
Valid QOF indicators would promote delivery of effec-
tive health interventions and, as most UK general practi-
tioners work to the QOF, such targets could have
massive potential for improving population health. For
maximal impact, indicators would need to be aimed at
people experiencing significant morbidity and to stimu-
late the use of interventions known to reduce this. As
long as delivered interventions are always (or almost
always) noted in patients’ records, audits demonstrating
QOF target achievement would also demonstrate
improved clinical care. The QOF indicator for recording
HBA1c levels in patients with diabetes (shown below) is
a good example of a high-validity and, therefore, high-
impact QOF indicator:
’The percentage of patients with diabetes in whom
the last HbA1c is 7.5* or less (or equivalent test/refer-
ence range depending on local laboratory) in the pre-
vious 15 months’
*GPs are rewarded for having a specified percentage
of patients with better than this level of control of
diabetes
Target patients are clearly defined as those with dia-
betes mellitus, a high-morbidity disease with clear diag-
nostic criteria, in which maintaining blood glucose at
lower levels reduces future harm [7]. It seems very likely
that this indicator will encourage clinical activities to
reduce diabetic patients’ blood glucose levels. Addition-
ally, as blood test results are almost always inserted
automatically into primary care medical records, audited
target compliance, which is based on medical records
data, should directly reflect the quality of effective medi-
cal care for diabetic patients. This and other, similarly
specific, indicators are probably responsible for the
improved management of diabetes stimulated by the
QOF [4,5]. However, not all QOF indicators are as well
targeted and, in particular, those which rely on GPs’
recording of counselling interventions may have effects
other than those originally intended. QOF indicators
related to smoking illustrate this phenomenon and are
discussed below.
QOF smoking indicators
Smoking is a major risk factor for many illnesses so,
recording smoking status in medical records is necessary
for good medical care. When this is noted prominently,
health professionals are more likely to deliver or offer
effective smoking cessation interventions [8]. like brief
advice against smoking [9], nicotine replacement therapy
(NRT) [10], bupropion [11] or varenicline [12]. Smoking
status data in medical records is generally valid [13], as
doctors are careful to accurately record this risk factor
which is so relevant to their patients’ health. Conse-
quently, QOF indicators for the ascertainment and
recording of smoking status could potentially have a
positive impact on public health and, in the original
2004 QOF, 8% of quality payments could be obtained
for smoking-related medical care. Smoking-orientated
QOF indicators (examples below) were written to pro-
mote the ascertainment of patients’ smoking status and
the provision of smoking cessation advice to smokers
and variations have been included in subsequent QOF
revisions:
‘The smoking status of patients age 15 - 75 is
recorded for at least 55 per cent of patients’
’The percentage* of patients with coronary heart dis-
ease who smoke, whose notes contain a record that
smoking cessation advice has been offered within the
last 15 months’
*GPs are rewarded for having recorded giving advice
to a specified percentage of smokers
GPs’ brief advice against smoking is essentially a sim-
ple, counselling intervention, delivered within patients’
routine consultations, lasting no more than five minutes
(often substantially less), during which doctors make
clear that smoking is harmful and offer help with cessa-
tion [8].
Trials in many different health care settings have
shown, unequivocally, that GPs’ brief cessation advice
against helps patients to stop smoking [8,14], so
encouraging GPs to give and also record such advice is
logical. However, GPs hold divergent opinions on what
constitutes effective advice against smoking [15]; the
‘advice’ they give can vary from the briefest mention of
smoking to detailed discussion of specific strategies to
assist cessation attempts. Consequently, what GPs enter
as ‘brief advice’ in patients’ medical notes is likely to
vary greatly and some may be prone to record even the
slightest mention of smoking. Also, the indicator above
rewards GPs for ‘offering’ rather than ‘giving’ advice,
potentially allowing clinicians latitude for deciding
whether or not to record that they have complied with
this target. Below, research describing the impact of
QOF smoking indicators on the delivery of primary care
smoking cessation interventions is interpreted and
discussed.
QOF: impact on cessation interventions
Figures 1 and 2, based on data from over 4 million sets
of primary care medical records contained in (The
Health Improvement Network) THIN research database,
show how the QOF initially affected documentation and
recorded use of smoking cessation interventions in UK
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being implemented, rates of smoking status ascertain-
ment almost doubled and of cessation advice recorded
in medical records nearly tripled and these substantial
increases were sustained throughout following year. If
these increases reflected real changes in clinical beha-
viour, then the impact of the QOF would be far higher
than that of other established methods of influencing
clinical behaviours like audit and feedback [17].
However, as no concomitant increase in the rate of
prescribing nicotine addiction treatments occurred (Fig-
ure 2), these apparent increases in other smoking cessa-
tion intervention rates need to be questioned. If GPs
really doubled their rates of enquiring about patients’
smoking status and also tripled their advice-giving, a
related but smaller increase in prescriptions for nicotine
addiction treatments would be expected. At least some of
the ‘extra’ discussions about smoking would have involved
smokers who intended to try stopping soon, because
20% of smokers feel this way about their habit [18]. One
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Figure 1 Quarterly incidence of smoking status ascertainment in general practice patients measured in The Health Improvement
Network database (2003-2005).
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Figure 2 Quarterly incidence of smoking cessation advice and prescriptions for nicotine replacement therapy and bupropion
combined issued to smokers as recorded in The Health Improvement Network database (2003-2005).
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either request or be offered and receive prescriptions for
nicotine addiction treatments to assist impending cessa-
tion attempts. The expected increase in prescribing rates
would probably be smaller than any increase in recorded
advice-giving because pharmacotherapy for cessation is
only appropriate for those smokers who are motivated
enough to try to stopping. However, the absence of any
change in prescribing, despite using a database with suffi-
cient power to detect much smaller effects than those
shown justifies a consideration of alternative explanations
for the apparent increase in advice giving. Below, expla-
nations for this discrepancy, based on previous research,
are presented.
More advice or better documentation?
GPs mention smoking in no more than 20% of smokers’
consultations [18], selecting out those with smoking
related problems and greater motivation to stop for
advice [19]. When deciding who to advise, GPs try to
avoid upsetting patients [20] and are more comfortable
discussing smoking with smokers who want to stop [15].
GPs don’t feel equipped with appropriate skills for
advising patients who are undecided or not motivated to
stop and usually curtail these consultations and also
those in which smokers react negatively to the mention
of smoking [15,21,22]. Most GPs’ discussions about
smoking are cursory, consisting of two questions, “Do
you smoke?” and “How many?” andwhen advice is given,
this usually involves simple exhortations to stop rather
than more specific instructions [19]. Given the caution
that GPs report in their approach to advising patients
on smoking, a tripling in their rate of doing so would
represent a very major change in their clinical
behaviour.
The principal impact of the QOF could merely have
been to increase GPs’ recording of their advice in
patients’ medical records instead of actually altering
GPs’ rates of advising smokers. Such an increased pro-
pensity of GPs for recording their cessation advice
would result in QOF compliance audits finding
improved achievement of smoking-related QOF targets,
without any or only minimal, increase in actual advice-
giving. Prior to the QOF, GPs chose whether or not
they documented advice against smoking in medical
records and only a small minority of all advice given
was documented [23]. GPs’ low rates of rates of record-
ing cessation advice appear relatively amenable to
change as, for example, distributing questionnaires
about smoking to patients sitting in doctors’ waiting
rooms, doubled GPs’ advice-recording without their
being any simultaneous increase in actual advice-giving
[24]. The QOF now motivates GPs to record all advice
against smoking in patients’ medical records and it is
plausible that the apparently QOF-related increases in
‘advice-giving’ are primarily due to increased rates of
documenting advice given in medical records, so that
QOF clinical indicators can be achieved and payments
earned. In response to the QOF, some UK general prac-
tices have introduced major alterations to their organi-
zation of chronic disease care [25,26]; in comparison,
increasing the completeness of documenting cessation
advice would be relatively easy. Since the QOF was
introduced, much chronic disease care has been dele-
gated to practice nurses working with electronic tem-
plates to record data for QOF indicators [25].
Consequently, patients’ smoking status is likely to have
been primarily determined outside of GPs’ consultations,
reducing the potential for GPs’ brief advice to be given
or nicotine addiction treatments prescribed.
Implications for smoking indicators
To have their intended, positive effects on unhealthy
behaviours, health promotion targets must be very care-
fully phrased [27]; evidence suggests that the current
QOF indicator for ‘offering’ smoking cessation advice is
not valid and alternatives are needed. A QOF indicator
which rewards prescribing of effective nicotine addiction
treatments to motivated smokers would be a logical
alternative. Electronic prescriptions are automatically
documented in medical records and prescribing is an
uncontroversial, uniform clinical activity; consequently,
compliance with a prescribing target could not be influ-
enced by GPs’ propensities to record their clinical beha-
viours in medical records. Increased prescribing would
also be likely to also result in more brief advice giving,
because GPs would need to talk to many smokers to
find those who were sufficiently motivated to benefit
from pharmacotherapy.
Implications for other QOF indicators
Evidence on smoking-orientated QOF indicators sug-
gests that targets for delivering health promotion coun-
selling may not result in advice or counselling actually
being delivered. Additional file 1 lists ‘counselling-type’
indicators from the 2009 QOF; these reward GPs for
giving information or advice on clinical issues such as
alcohol intake, where the consensus about appropriate
health promotion advice for individuals is less clear cut.
One indicator rewards the provision of the following
advice to those suffering from mental health conditions,
“routine health promotion and prevention advice appro-
priate to their [i.e. the patient’s] age, gender and health
status” and quite what kind of advice giving this is
intended to encourage is unclear. The QOF undoubtedly
affects clinical behaviour and unambiguous indicators
for clearly-defined, effective interventions (e.g. prescrib-
ing drugs or performing and recording diagnostic tests)
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more caution is required when developing targets for
less easily-defined, health promotion counselling inter-
ventions which clinicians document having given in
medical records; it is very possible that these targets are
not valid and don’t stimulate intended health promotion
counseling activity.
Wider implications for health promotion
Despite the apparent success of the QOF in improving
some aspects of clinical care, it has been criticised as
being an obstacle to patient-centred medicine [28], for
not sufficiently remunerating the extra effort required
by practices working in deprived areas [29] and for
encouraging neglect of clinical areas for which there are
no clinical indicators [30]. The QOF’s utility for
encouraging effective health promotion counselling
appears questionable and whether incentives payments
are ever appropriate for this is open to debate. Health
promotion payments were introduced into UK primary
care in 1990 [31]; initially health promotion activity
undertaken in specially-organised clinics, rather than
during routine consultations was incentivised but soon
discontinued on cost grounds; evaluation provided no
evidence that, if continued, this health promotion
approach would have been effective [32]. Subsequently,
another primary care health promotion scheme invol-
ving target payments for recording cardiovascular risk
factors and giving lifestyle advice to patients was intro-
duced, but this too was quickly scrapped [33,34]. Like
the QOF, this system rewarded GPs for counselling
patients and also relied on the doctors themselves to
record when they had done this. Evaluation suggested
that doctors principally made administrative changes in
their recording of patients’ lifestyle data to enable incen-
tives to be claimed, rather than substantially altering
preventive activities [34]. Similarly, in an experimental
study monitoring the introduction of an outcome based
health promotion payment, in which GPs were remun-
erated for recording three month’s abstinence from
smoking by patients also encouraged administrative
changes made to facilitate payment claims rather than
meaningful clinical interventions against smoking [27].
Summary
The utility of the QOF for increasing the use of effec-
tive, health promotion counselling interventions is ques-
tionable and the impact of current indicators aimed at
achieving this should be rigorously-evaluated before
additional similar targets are set. The revision process,
led by the National Institute for Clinical Excellence [35],
should aim to ensure that the QOF remains as relevant
as possible to primary medical care and, therefore,
needs to include an assessment of whether individual
QOF indicators are having their desired effects, with
those considered non-valid being modified or rejected.
Additional file 1: Clinical indicators for health promotion
counselling-type interventions in the 2009 QOF. This lists clinical
indicators contained in the 2009 QOF which relate to ‘counselling-type’
interventions.
Abbreviations
UK: United Kingdom; GP: General Practitioner; QOF: Quality Outcomes
Framework; HbA1c: Haemogloblin A1c; THIN: The Health Improvement
Network (a research database containing primary care medical records).
Acknowledgements
Tim Coleman is a member of the UK Centre for Tobacco Control, a UKCRC
Public Health Research: Centre of Excellence. Funding from the British Heart
Foundation, Cancer Research UK, Economic and Social Research Council,
Medical Research Council and the Department of Health, under the auspices
of the UK Clinical Research Collaboration is gratefully acknowledged. The
author is also grateful to Clare Randall for help with preparing this
manuscript.
Authors’ contributions
TC is the sole author of this paper because there have been no other
contributors.
Competing interests
The author declares that, in the last 5 years, he has been paid for
consultancy work by Johnson and Johnson and Pierre Fabre Laboratories
(manufacturers of nicotine replacement therapy). However, this manuscript
has not been discussed with any third parties.
Received: 6 November 2009 Accepted: 26 March 2010
Published: 26 March 2010
References
1. Department of Health: Investing in general practice: the new general
medical services contract. London, Department of Health 2004.
2. Roland M: Linking Physicians’ Pay to the Quality of Care – A Major
Experiment in the United Kingdom. The New England Journal Of Medicine
2004, 351:1448-1454.
3. Carlisle D: Quality and outcomes framework. Points mean prizes for GPs,
but what’s in it for patients? Health Serv J 2005, 115:16-17.
4. Campbell SM, Roland MO, Middleton E, Reeves D: Improvements in quality
of clinical care in English general practice 1998-2003: longitudinal
observational study. BMJ 2005, 331:1121.
5. Campbell S, Reeves D, Kontopantelis E, Middleton E, Sibbald B, Roland M:
Quality of Primary Care in England with the Introduction of Pay for
Performance. New England Journal of Medicine 2007, 357:181-190.
6. Lester H, Roland M: Future of quality measurement. BMJ 2007,
335:1130-1131.
7. Effect of intensive blood-glucose control with metformin on complications
in overweight patients with type 2 diabetes (UKPDS 34): UK Prospective
Diabetes Study (UKPDS) Group. [erratum appears in Lancet 1998 Nov
7;352(9139):1558]. Lancet 1998, 352:854-865.
8. The Clinical Practice Guideline Treating Tobacco Use and Dependence
2008 Update Panel, Liaisons, and Staff. A Clinical Practice Guideline for
Treating Tobacco Use and Dependence: A US Public Health Service
Report. 2008 [http://www.surgeongeneral.gov/tobacco/].
9. Stead LF, Bergson G, Lancaster T: Physician advice for smoking cessation.
Cochrane Database of Systematic Reviews 2008, CD000165.
10. Stead LF, Perera R, Bullen C, Mant D, Lancaster T: Nicotine replacement
therapy for smoking cessation. Cochrane Database of Systematic Reviews
2008, CD000146.
11. Hughes JR, Stead LF, Lancaster T: Antidepressants for smoking cessation.
[update of Cochrane Database Syst Rev. 2004;(4):CD000031; PMID:
15494986]. Cochrane Database of Systematic Reviews 2007, CD000031.
Coleman BMC Public Health 2010, 10:167
http://www.biomedcentral.com/1471-2458/10/167
Page 5 of 612. Cahill K, Stead LF, Lancaster T: Nicotine receptor partial agonists for
smoking cessation. Cochrane Database of Systematic Reviews 2007,
CD006103.
13. Wilson A, Manku-Scott T, Shepherd D, Jones B: A comparison of individual
and population smoking data from a postal survey and general practice
records. Br J Gen Pract 2000, 50:465-468.
14. Ashenden R, Silagy C, Weller D: A systematic review of the effectiveness
of promoting lifestyle change in general practice. Family Practice 1997,
14:160-176.
15. Coleman T, Cheater F, Murphy E: Qualitative study investigating the
process of giving anti-smoking advice in general practice. Patient
Education and Counseling 2004, 52:159-163.
16. Coleman T, Lewis S, Hubbard R, Smith C: Impact of contractual financial
incentives on the ascertainment and management of smoking in
primary care. Addiction 2007, 102:803-808.
17. Jamtvedt G, Young JM, Kristoffersen DT, O’Brien MA, Oxman AD,
Jamtvedt G, et al: Does telling people what they have been doing
change what they do? A systematic review of the effects of audit and
feedback. Quality & Safety in Health Care 2006, 15:433-436.
18. Coleman T, Wynn AT, Barrett S, Wilson A, Adams S: Intervention study to
evaluate pilot health promotion payment aimed at increasing general
practitioners’ antismoking advice to smokers. BMJ 2001, 323:435-436.
19. Coleman T: Anti-smoking advice in general practice consultations: a
description of factors influencing provision of advice and the developement of
a method for describing smokers’ responses. [MD thesis] University of
Leicester 1998.
20. Coleman T, Murphy E, Cheater FC: Factors influencing discussions about
smoking between general practitioners and patients who smoke: a
qualitative study. British Journal of General Practice 2000, 50:207-210.
21. Pilnick A, Coleman T: “I’ll give up smoking when you get me better":
patients’ resistance to attempts to problematise smoking in general
practice (GP) consultations. Social Science & Medicine 2003, 57:135-145.
22. Pilnick A, Coleman T, Pilnick A, Coleman T: Death, depression and
‘defensive expansion’: closing down smoking as an issue for discussion
in GP consultations. Social Science & Medicine 2006, 62:2500-2512.
23. Wilson A, McDonald P: Comparison of patient questionnaire, medical
record, and audio tape in assessment of health promotion in general
practice consultations. BMJ 1994, 309:1483-1485.
24. Coleman T, Wilson A, Barrett S, Wynne A, Lewis S: Distributing
questionnaires about smoking to patients: impact on general
practitioners’ recording of smoking advice. BMC Health Services Research
2007, 7:153.
25. McDonald R, Harrison S, Checkland K, Campbell SM, Roland M: Impact of
financial incentives on clinical autonomy and internal motivation in
primary care: ethnographic study. [see comment]. BMJ 2007, 334:1357.
26. Campbell SM, McDonald R, Lester H, Campbell SM, McDonald R, Lester H:
The experience of pay for performance in english family practice: a
qualitative study. Annals of Family Medicine 2008, 6:228-234.
27. Coleman T, Wynn AT, Stevenson K, Cheater F: Qualitative study of pilot
payment aimed at increasing general practitioners’ antismoking advice
to smokers. BMJ 2001, 323:432-435.
28. Mangin D, Toop L: The Quality and Outcomes Framework: what have
you done to yourselves?. Br J Gen Pract 2007, 57:435-437.
29. Guthrie B, McLean G, Sutton M: Workload and reward in the Quality and
Outcomes Framework of the 2004 general practice contract. Br J Gen
Pract 2006, 56:836-841.
30. Gubb JD: Commentary: unintended consequences: what of quality
outside the QOF?. Br J Gen Pract 2009, 59:e173-e174.
31. Department of Health: General practice in the National Health Service: a new
contract London: HMSO 1989.
32. Dowell AC, Ocheran JJ, Hilton SR, Bland JM, Harris T, Jones DR: Prevention
in practice: Results of a 2-year follow-up of routine health promotion
interventions in general practice. Family Practice 1996, 13:357-362.
33. LeTouze S, Calnan M: Evaluation of the new health promotion package for
general practice Canterbury: Centre for Health Service Studies, University of
Kent 1995.
34. LeTouze S: Health promotion in general practice: the views of staff.
Nursing Times 1996, 92:32-33.
35. NICE set to revise Quality and Outcomes Framework indicators. Lancet
2009, 374:588.
Pre-publication history
The pre-publication history for this paper can be accessed here: http://www.
biomedcentral.com/1471-2458/10/167/prepub
doi:10.1186/1471-2458-10-167
Cite this article as: Coleman: Do financial incentives for delivering
health promotion counselling work? Analysis of smoking cessation
activities stimulated by the quality and outcomes framework. BMC
Public Health 2010 10:167.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Coleman BMC Public Health 2010, 10:167
http://www.biomedcentral.com/1471-2458/10/167
Page 6 of 6